UNDEFINED: wu-login-soft-user-unknown

CzMA JEP: Current issue
For authors and reviewers


Authors: Pavelková A., Pavelka K.

Authors - sphere of activity: Revmatologický ústav, Praha

Article: Čes. Revmatol., , 2000, No. 2, p. 57-61.
Number of articles displayed: 3986x

Specialization: Dermatology & STDs Paediatric rheumatology Rheumatology


The authors present the pharmacological profile and an account of the clinical effectiveness ofdiacerein. It is a preparation which inhibits above all the production and activity of interleukin-1(IL-1) as well as other cytokines and catabolic enzymes which participate in the degradation ofcartilage in osteoarthritis (OA). The implemented clinical studies provide evidence of its effective-ness on pain and function in patients with hip and knee osteoarthritis. As to the character of itseffect diacerein belongs to so-called SYSADOA, symptomatically slow acting drugs in OA. The onsetof its effect is as compared with NSA retarded, the onset being after 2-4 weeks. Then its effectivenessis identical as that of NSA. While after discontinuation of NSA treatment the patients exacerbatesas a rule, after termination of diacerein treatment the favourable effect persists for another 2-3months. A recently completed study revealed that in addition to the purely symptomatic effect afterlong-term diacerein treatment the progression of OA is perhaps slower. Thus a drug potentiallymodifying the structure is involved. The assembled results will have to be confirmed in furtherinvestigations. Diacerein is a safe preparation, the main undesirable effect is diarrhoea whichhowever occurs only at the onset of treatment and as a rule does not lead to discontinuation oftherapy.

Key words:
osteoarthritis, diacerein, therapy, SYSADOA


Rate article

Rate article:     2,8/5, evaluated 34x

Read more

Možnosti predikce rentgenové progrese revmatoidní artritidy

Pavelka K., Gatterová J.
Česká revmatologie

Kognitivní dysfunkce u české populace nemocných se systémovým lupus erytematodes

Svobodová R, Pošmurová M, Peterová V, Kozelek P, Půtová I, Fojtíková M, Dostál C, Olejárová M.
Česká revmatologie

Súčasný pohľad na genetiku alkaptonúrie

Bošák V.
Česká revmatologie

Raynaudův fenomén a periferní ischemické syndromy

Karetová D.
Česká revmatologie

Ultrazvuková detekce entezitid u pacientů se spondyloartritidou

Hurňáková J, Horváth R,2, Gatterová J, Pavelka K
Česká revmatologie

Účinnost první a následné linie léčby 
adalimumabem u revmatoidní artritidy: analýza dat Českého národního registru ATTRA

Horváth R, Hurňáková J, Janková R, Philipp T, Szczuková L, Hejduk K, Pavelka K
Česká revmatologie